OXFENDAZOLE DEVELOPMENT GROUP
Data sourced from IRS 990 public filings
OXFENDAZOLE DEVELOPMENT GROUP Research and development of pharmaceutical treatments to help eliminate neglected tropical diseases especially oxfendazole through nonclinical work and the conduct of clinical studies
Local (City/County Level)
Research & Evaluation
Medical Research
Health
Annual Revenue
$23,366
Known Funders
2
Grants Received
2
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $23,366 | $851,968 | $318,287 |
| 2023 | $58,517 | $604,664 | $1,146,889 |
| 2022 | $1,710,127 | $42,614 | $1,721,909 |
Top Funders
EFFECTIVE VENTURES FOUNDATION USA INC
SAN FRANCISCO, CA
$101,430 (2021)
Unknown foundation
$43 (2023)
Key Personnel
From 2024 IRS 990 filing
J
Javier Bustos
Board member
T
Timothy Geary
Secretary Board member
Officer
R
Robert H Gilman
Board Member
E
Ellen Codd
Treasurer Board Member
Officer
R
R John Horton
President Board Member
Officer
Frequently Asked Questions
Other Nonprofits in Pennsylvania
UPMC GROUP$24,322,528,674
NATIONAL PHILANTHROPIC TRUST$15,875,636,840
VANGUARD CHARITABLE ENDOWMENT PROGRAM$6,410,999,905
Highmark Health Group$6,059,666,088
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA$6,000,839,000
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.